Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Common Stock | Options Exercise | +28.9K | +271.14% | 39.5K | Mar 7, 2024 | Direct | F1 | ||
transaction | NVAX | Common Stock | Tax liability | -$78.3K | -14K | -35.29% | $5.61 | 25.6K | Mar 7, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -28.9K | -100% | $0.00* | 0 | Mar 7, 2024 | Common Stock | 57.8K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
F2 | One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date. |